Recurrent lupus nephritis post-transplant may go undetected without surveillance biopsies. This study reveals high recurrence ...

ProKidney stock jumps after Phase 2 trial shows rilparencel significantly slowed kidney function decline in patients with ...

Georgia high school student Gabrielle Culberson was in desperate need of a kidney transplant, and the chances of finding a ...

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

At one point, ProKidney had been running an international phase 3 trial, dubbed PROACT 2, of rilparencel alongside the ...

ProKidney Corp. (NASDAQ:PROK) saw its stock skyrocket 115% following the release of positive topline results from its Phase 2 ...

GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different doctor. Ultimately, what you do is up to you, ...

ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the kidneys and manifests with protein spillage into th ...

This story was originally reported by Chabeli Carrazana of The 19th. Two years ago, Nicolle Orozco Forero walked into an ...

Shares of ProKidney Corp (NASDAQ: PROK) soared more than 25% in Thursday afternoon trading after the company reported ...

Kidney transplant recipients who receive donor-derived hematopoietic stem cells may be able to discontinue immunosuppressive ...